Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Title
Intervention Indication Therapeutic Area Year Actions
Leuprorelin acetate in addition to tamoxifen or an aromatase inhibitor for ER-positive early stage breast cancer in premenopausal women - adjuvant Leuprorelin acetate (Prostap DCS; Prostap Depot) , Tamoxifen Breast cancer Breast Cancer 2018 View  |  Download
Lisocabtagene Maraleucel (Liso-Cel) for Relapsed/Refractory Diffuse Large B-cell Lymphoma Lisocabtagene maraleucel (Liso-cel; JCAR017) Diffuse large B-cell lymphoma (DLBCL) Haematological Cancer and Lymphomas 2018 View  |  Download
Lumacaftor and Ivacaftor (Orkambi) for Cystic Fibrosis Homozygous for the F508del CFTR mutation in patients aged 2-5 years old Orkambi (fixed dose combination: Lumacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2018 View  |  Download
Lumacaftor and Ivacaftor (Orkambi) for Cystic Fibrosis Homozygous for the F508del Mutation in Patients Aged 6‐11 Years Orkambi (fixed dose combination: Lumacaftor; Ivacaftor) Cystic fibrosis Genetic Disorders , Respiratory System 2018 View  |  Download
Luspatercept for adult patients with beta-thalassemia who require red blood cell transfusions Luspatercept (ACE-536; Reblozyl) Beta thalassemia Genetic Disorders , Haematology 2018 View  |  Download
Luspatercept for myelodysplastic syndromes (MDS) associated anaemia Luspatercept (ACE-536; Reblozyl) Anaemia due to myelodysplastic syndromes (MDS) Haematological Cancer and Lymphomas , Haematology 2018 View  |  Download
Mexiletine for the Symptomatic Treatment of Myotonic Disorders – First Line Mexiletine hydrochloride (Namuscla) Myotonia Musculoskeletal System , Neurology 2018 View  |  Download
Mirvetuximab Soravtansine for Platinum-resistant Ovarian Cancer Mirvetuximab soravtansine (IMGN853) Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer Female Reproductive Cancer 2018 View  |  Download
Naloxone Auto-injector (Evzio) for Opioid Substance Use Disorder Naloxone hydrochloride (Evzio; Narcan; OPNT001; Nalscue; Nalcol; E-0316) Opioid overdose Toxicology 2018 View  |  Download
Nefecon (targeted-release budesonide formulation) for IgA Nephropathy (Berger's disease) Budesonide targeted-release (Nefecon; PL-56) IgA nephropathy Immunology , Nephrology 2018 View  |  Download
1 2 6 7 8 9 10 14 15
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications